Dynamics of HIV DNA and residual viremia in patients treated with a raltegravir-containing regimen

J Acquir Immune Defic Syndr. 2015 Feb 1;68(2):e18-20. doi: 10.1097/QAI.0000000000000414.
No abstract available

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anti-HIV Agents / therapeutic use*
  • DNA, Viral / blood*
  • HIV / isolation & purification
  • HIV Infections / drug therapy*
  • HIV Infections / virology*
  • Humans
  • Pyrrolidinones / therapeutic use*
  • Raltegravir Potassium
  • Viral Load*
  • Viremia*

Substances

  • Anti-HIV Agents
  • DNA, Viral
  • Pyrrolidinones
  • Raltegravir Potassium